Rolfo, CHRISTIAN DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 5.468
AS - Asia 1.657
EU - Europa 1.545
Continente sconosciuto - Info sul continente non disponibili 286
SA - Sud America 237
AF - Africa 29
OC - Oceania 3
Totale 9.225
Nazione #
US - Stati Uniti d'America 5.391
SG - Singapore 694
RU - Federazione Russa 475
CN - Cina 413
IT - Italia 310
BR - Brasile 184
HK - Hong Kong 149
VN - Vietnam 137
DE - Germania 123
FI - Finlandia 113
GB - Regno Unito 107
PL - Polonia 96
FR - Francia 72
IE - Irlanda 68
JP - Giappone 47
KR - Corea 47
CA - Canada 44
SE - Svezia 41
BD - Bangladesh 32
IN - India 30
ES - Italia 23
RO - Romania 19
TR - Turchia 18
AR - Argentina 16
AT - Austria 15
BE - Belgio 15
IQ - Iraq 13
UA - Ucraina 13
IR - Iran 11
EC - Ecuador 10
UZ - Uzbekistan 10
NL - Olanda 9
MX - Messico 8
VE - Venezuela 8
CH - Svizzera 7
AL - Albania 6
CR - Costa Rica 6
ID - Indonesia 6
LB - Libano 6
PY - Paraguay 6
ZA - Sudafrica 6
CI - Costa d'Avorio 5
GR - Grecia 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
PK - Pakistan 5
CL - Cile 4
CZ - Repubblica Ceca 4
IL - Israele 4
JM - Giamaica 4
SV - El Salvador 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
KE - Kenya 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
SA - Arabia Saudita 3
TH - Thailandia 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
PE - Perù 2
TW - Taiwan 2
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
KY - Cayman, isole 1
LV - Lettonia 1
MC - Monaco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 8.939
Città #
Fairfield 723
Ashburn 596
Singapore 475
San Jose 356
Woodbridge 355
Seattle 315
Houston 311
Chandler 307
Cambridge 276
Wilmington 258
Ann Arbor 167
Hong Kong 144
Council Bluffs 108
Moscow 89
Beijing 88
Zgierz 81
Palermo 78
Medford 67
Dublin 64
Los Angeles 54
Chicago 52
Altamura 51
New York 51
Santa Clara 49
Helsinki 46
Tokyo 44
Boardman 43
Princeton 42
The Dalles 42
Des Moines 41
Ho Chi Minh City 41
Nanjing 41
Lauterbourg 38
Lawrence 38
Hanoi 37
Twinsburg 32
San Diego 29
Dallas 28
Dearborn 25
London 25
Phoenix 25
Panama City 24
Frankfurt am Main 23
Nanchang 19
Ludwigshafen am Rhein 17
Orem 17
Redwood City 17
Rome 17
Shenyang 17
Buffalo 15
Changsha 15
Brussels 14
Tianjin 14
Toronto 13
São Paulo 12
Warsaw 12
Da Nang 11
Hebei 11
Jinan 11
Tulsa 11
Guangzhou 10
Jiaxing 10
Milan 10
San Paolo di Civitate 10
Zhengzhou 10
Brooklyn 9
Denver 9
Hefei 9
Milazzo 9
Baghdad 8
Columbus 8
Izmir 8
Seongnam 8
Seoul 8
Shanghai 8
Belo Horizonte 7
Boston 7
Falkenstein 7
Madrid 7
Ningbo 7
Philadelphia 7
Tashkent 7
Atlanta 6
Bremen 6
Chennai 6
Hangzhou 6
Kitzingen 6
Madison 6
Manchester 6
Montreal 6
Naples 6
Tirana 6
Washington 6
Abidjan 5
Amsterdam 5
Asunción 5
Barcelona 5
Dhaka 5
Forest City 5
Haiphong 5
Totale 6.306
Nome #
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 355
Entrectinib: A potent new TRK, ROS1, and ALK inhibitor 293
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 287
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 283
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 280
Exosomes in semen: Opportunities as a new tool in prostate cancer diagnosis 267
Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21 267
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 258
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 258
Cancer and the microbiome: Potential applications as new tumor biomarker 258
Effects of exosomes released by NSCLC cells on osteoclasts differentiation. 247
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward 242
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice 239
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 235
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 233
Multisciplinary management of patients with liver metastasis from colorectal cancer 233
Exosomes as diagnostic and predictive biomarkers in lung cancer 222
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool 213
Targeting angiogenesis in biliary tract cancers: An open option 212
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 209
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 208
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 208
In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment 198
Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter 198
Role of NSCLC exosomes in osteoclast differentiation 196
Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found… 191
Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition 187
EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy 186
BRAF mutations in non-small cell lung cancer: Has finally Janus opened the door? 183
Improving extracellular vesicles visualization: From static to motion 183
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it 179
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 176
Curcumin induces selective packaging of miR-21 in exosomes released by Chronic Myelogenous Leukemia cells 167
Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential 166
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 161
VIPoma and PPoma 155
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 154
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib 154
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 153
Ramucirumab and its use in gastric cancer treatment 147
Upfront radiation versus EGFR-TKI: Which is the best approach for EGFR-mutated NSCLC patients with brain metastasis? 147
Indications for locoregional tumor therapies: CRC liver metastases 125
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 122
Liquid biopsy: a right tool in a right context? 85
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors 52
Abstract 2055: Isoform-aware miRNA network mapping in NSCLC via computational consensus targeting and functional clustering 37
null 16
Totale 9.225
Categoria #
all - tutte 32.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022406 0 0 0 20 19 27 20 45 61 81 45 88
2022/2023811 73 168 36 112 83 122 29 61 66 3 39 19
2023/2024363 14 48 26 26 19 56 63 23 18 11 3 56
2024/2025848 11 69 81 71 37 34 40 76 49 79 130 171
2025/20262.703 226 85 146 179 308 379 394 335 228 207 92 124
2026/2027602 197 95 294 16 0 0 0 0 0 0 0 0
Totale 9.225